MassDevice asks the CEOs of Zoll Medical, Semprus Biosciences, IlluminOss Medical and Good Start Genetics what keeps them up at night at the 2011 MassDevice.com Big 100 Roundtable East.
Zoll Medical
Zoll appoints first data management solutions medical director
Did a last-minute visit from med-tech CEOs change Rep. Tsongas’ mind on device tax vote?
It would be a stretch to call it an offer she couldn’t refuse, but in the end what choice did Rep. Niki Tsongas (D-Mass.) have but to consider the pleas of the men in her Capitol Hill office last Thursday?
Tsongas represents a stretch of Massachusetts that runs from the edge of Natick to the tip of New Hampshire and includes the lion’s share of the I-495 beltway, where you can’t throw a trocar without hitting a company that either makes a medical device or services a medical device company.
Medical device tax: Zoll CEO Packer says levy will lead to permanent job losses and higher healthcare costs
MassDevice.com +3 | The top 3 med-tech stories for May 15, 2012.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
SEC closed probe of Zoll’s Middle East sales just ahead of $2.3B Asahi merger
Asahi closes 2nd phase of $2.2B Zoll buyout
New J&J CEO Gorsky wants to grow device business | Wall Street Beat
When Alex Gorsky takes the helm at Johnson & Johnson (NYSE:JNJ) tomorrow, he’ll become responsible for a company bedeviled by a series of high-profile, big-ticket recalls, a more than $1 billion legal settlement – and blessed with the world’s largest medical device business.
Asahi Kasei closes $2.3B tender for Zoll Medical
Chelmsford, Mass.-based resuscitation device maker Zoll Medical (NSDQ:ZOLL) sealed the deal with Japan’s Asahi Kasei Corp. (TYO:3407) over the weekend.
HRS preview: St. Jude, Boston Scientific in the spotlight | Wall Street Beat
The foofaraw over St. Jude Medical‘s (NYSE:STJ) recalled Riata defibrillator leads is slated for top billing at the upcoming annual meeting of the Heart Rhythm Society in Boston, according to a pair of Leerink Swann analysts.
Gingrich’s health consulting group goes under | Wall Street Beat
The Center for Health Transformation, a health care think tank launched by GOP presidential hopeful Newt Gingrich, filed for Chapter 7 bankruptcy this week, listing liabilities of between $1 million and $10 million that it says it can’t repay.
The organization’s assets, which it listed in court filings at between $50,000 and $100,000, will be liquidated and the business may subsequently close.